GlassScriptPhysician profile
Cecil T Hollen
NPI 1821433970
$3,809.27
in general payments reported to CMS, 2019-2025
7 companies · $706 in 2025
The $706 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.91 · 2020: $373 · 2021: $488 · 2022: $402 · 2023: $1,252 · 2024: $538 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,628 · Travel and Lodging: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,627.88 |
| Travel and Lodging | $867.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,667.75 | 2022-2025 | |
| Allergan, INC. | $1,044.45 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $789.97 | 2023 | Iovera |
| Spr Therapeutics, INC | $233.64 | 2023-2025 | Sprint Pns System |
| Avanir Pharmaceuticals, INC. | $38.59 | 2022 | |
| Smith+Nephew, INC. | $23.65 | 2024 | Collagenase Santyl |
| Coloplast Corp | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecil Hollen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.